FDA reviewing first OTC birth control application
HRA Pharma has applied to the FDA to switch its daily oral contraceptive from a prescription to an over-the-counter drug.
Source: politico.com
Stay updated with breaking news from Phlow Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HRA Pharma has applied to the FDA to switch its daily oral contraceptive from a prescription to an over-the-counter drug.
Though Phlow Corp. has fulfilled some parts of its $354-million contract, it’s failed to deliver on its two-year deadline.
Virginia's governor says the work being done now and in the future at AMPAC Fine Chemicals has an impact locally statewide, and nationally.
06/07/22 Pharmaceutical Online Newsletter
04/12/22 Pharmaceutical Online Newsletter